Home › Funds › Octagon Capital Advisors LP › DFTX
Octagon Capital Advisors LP position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
Octagon Capital Advisors LP reported holding 2,950,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$138.8M, representing 12.47% of its reported portfolio and ranking #2 among its reported holdings. Octagon Capital Advisors LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's DFTX position evolved
Octagon Capital Advisors LP first disclosed a stake in DFTX in Q1 2026 at 2,440,000 shares (US$46.1M). The position peaked in Q2 2026 at 2,950,000 shares, worth US$138.8M. Across 2 filings, Octagon Capital Advisors LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,950,000 shares valued at US$138.8M — an increase of 510,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.44M | $46.12M | New |
| Q2 2026 | 2.95M | $138.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 189 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Deep Track Capital, LP (US$129.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Siren, L.L.C. 1.42M sh · $66.77M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- AWM Investment Company, Inc. 784.80K sh · $36.92M · Q2 2026
- ArrowMark Colorado Holdings LLC 564.07K sh · $26.53M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held DFTX?
Octagon Capital Advisors LP has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Octagon Capital Advisors LP's current position in DFTX?
As of Q2 2026, Octagon Capital Advisors LP holds 2.95M shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $138.77M, representing 12.47% of its reported portfolio and ranking #2.
Has Octagon Capital Advisors LP been buying or selling DFTX?
In the latest 13F filing (Q2 2026), Octagon Capital Advisors LP increased its position in DFTX. The position peaked in Q2 2026 at 2.95M shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, among 189 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.